By vgreene, 27 September, 2017 Kaposi sarcoma. Evidence for a statistical assoc b/t cannabis use and KS incidence is insufficient/none [I/N], per NAS2
By vgreene, 27 September, 2017 NHL. Evidence for a statistical assoc b/t cannabis use and NHL incidence is insufficient/none [I/N], per NAS2
By vgreene, 27 September, 2017 Malignant glioma. Evidence for a statistical assoc b/t cannabis use and malignant glioma incidence is insufficient/none [I/N], per NAS2
By vgreene, 27 September, 2017 Esophageal CA. Evidence for a statistical assoc b/t cannabis smoking and esophageal CA incidence is insufficient/none [I/N], per NAS2
By vgreene, 27 September, 2017 Prostate/Cervical/Penile/Bladder/Anal CA. Evidence for a statistical assoc b/t cannabis use and prostate, cervical, penile, bladder, or anal CA incidence is insufficient/none [I/N], per NAS.2 A VA-commissioned review3 concluded that the evidence for canna
By vgreene, 27 September, 2017 Testicular nonseminoma germ cell tumors. Evidence for a statistical assoc b/t current, frequent, or chronic cannabis smoking and nonseminoma testicular germ cell tumor incidence is limited [L], per NAS.2 A VA-commissioned review3 concluded that the eviden
By vgreene, 27 September, 2017 Head & neck CA. Evidence for no statistical assoc b/t cannabis use and head & neck CA incidence is moderate [M], per NAS.2 A VA-commissioned review3 concluded that there’s low-strength evidence that light to moderate cannabis use isn’t associated w/ incre
By vgreene, 27 September, 2017 Lung CA. Evidence for no statistical assoc b/t cannabis smoking and lung CA incidence is moderate [M], per NAS.2 A VA-commissioned review3 found that there’s low-strength evidence that light to moderate cannabis use isn’t associated w/ lung CA
By vgreene, 27 September, 2017 Diabetes Metabolic syndrome Evidence is limited L for a statistical association between cannabis use and darr metabolic syndrome risk darr diabetes risk or uarr prediabetes risk 1
